choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Organon USA Inc.

Organon USA Inc. Newsletter
  • Organon and QC LGU empower women to ‘Take Control’ on World Contraception Day 27 Nov 2025 03:25 GMT

    … celebration of World Contraception Day, Organon Philippines and the Quezon City … their bodies and their futures. Organon Asia & the Pacific Medical …

  • Vital Force and Its Relation to Health: A Study of Aphorism 9 in Organon of Medicine 26 Nov 2025 12:44 GMT

    … aphorisms in 6th edition of Organon of Medicine,  based on the … aphorisms 9 to 17 of Organon Of  Medicine.  • The Aphorism 9 …

  • Organon and UNFPA advance reproductive health services 20 Nov 2025 13:01 GMT

    … Population Fund (UNFPA) and Organon Vietnam signed an agreement … sexual and reproductive health. Organon is deeply committed to … Nations Population Fund and Organon, witnessed by the Vietnam … to ensure lasting impact. Organon is a global pharmaceutical …

  • Henlius, Organon win US FDA approval of first Perjeta biosimilar 18 Nov 2025 23:10 GMT

    Shanghai Henlius Biotech Inc. and Organon & Co. announced Nov. 17 …

  • US FDA approves Henlius and Organon’s Poherdy, the first Perjeta biosimilar 18 Nov 2025 11:21 GMT

    … and supply agreement with Organon, granting Organon the exclusive commercialization rights … diseases and ophthalmic diseases.  Organon is a global healthcare company … Medicines, which includes biosimilars, Organon focuses on addressing health needs …

  • 復宏漢霖與Organon共同宣佈美國首個帕妥珠單抗生物類似藥POHERDY®獲FDA批准 17 Nov 2025 20:37 GMT

    … 關於  Organon Organon（紐約證券交易所代碼：OGN）是一家全球化醫療健康公司，以提供創新性的藥品和解決方案，實現更健康的每一天為使命。Organon在全球提供超過70種藥物和醫療解決方案，並持續推動這些亟需療法在超140個市場的廣泛可及，重點業務包括女性健康、經典產品和生物類似藥，專注於為女性特有疾病、對女性影響重大或不同的疾病尋求解決方案。 Organon總部設在美國新澤西州澤西市，致力於提升醫藥健康領域的可及性、可負擔性和創新發展。訪問 www.organon.com …

  • Henlius and Organon score first US Perjeta biosimilar approval 17 Nov 2025 20:47 GMT

    … brand alternatives more easily. Organon’s commercial hurdle Following … Poherdy’s approval, Organon will be responsible for … its biosimilar portfolio, as Organon also acquired the rights … Shanghai Henlius Biotech and Organon are infringing on 24 …

  • Organon and Henlius' Poherdy, first biosimilar to Roche's Perjeta, scores FDA nod 15 Nov 2025 00:57 GMT

    … s Prolia-Xgeva duo—to Organon in 2022. The FDA … It’s not clear whether Organon can immediately launch Poherdy. In … infringement lawsuit against Henlius and Organon in August, asserting arguments … of patents on Perjeta. Organon did not immediately respond to …

  • Laborie to acquire Organon’s JADA System for $465M 12 Nov 2025 21:28 GMT

    … A spinoff of Merck, Organon brought on JADA with its … to debt reduction.  The Organon board of directors has … hemorrhage (PPH) management,” Organon interim CEO Joseph Morrissey said … countries… – Joseph Morrissey, Organon interim CEO Morrissey recently took …

  • Organon Analysts Cut Their Forecasts Following Q3 Results 11 Nov 2025 17:17 GMT

    … of $1.56 billion. Organon lowered its fiscal sales … pivotal time for Organon,” said Joe Morrissey, Organon’s Interim … to their price targets on Organon following earnings announcement. Morgan … analyst Terence Flynn maintained Organon with an Equal-Weight …

Satisfied with the content?

Continue to create your account.